How To Respond to Health Authority Questions
Your biotech company has just submitted the marketing application for your first drug product. It’s…
Danielle Pillsbury2024 年 10 月 25 日
Certara Establishes Certainty Conference in Europe, Creating Space for Drug Development Leaders to Convene
Clients are invited to join Certara at this two-day event to further explore and connect…
Danielle Pillsbury2024 年 10 月 24 日
CDISC SDTM – 5 Implementation Challenges Solved
Read this guide to find out the 5 common CDISC SDTM implementation challenges and the…
Simona Colucci2024 年 10 月 24 日
How to Automate CRF Annotations – A Best Practice Guide
This free guide explores how to automate CRF annotations, the benefits of automation, and the…
Simona Colucci2024 年 10 月 24 日
Certara Releases Environmental, Social and Governance Report
Report details commitment to understanding, monitoring, and managing social and environmental responsibilities. RADNOR, Pa. —…
Danielle Pillsbury2024 年 10 月 23 日
Three Strategies for Navigating the Pharmaceutical Patent Cliff
In the pharmaceutical industry, the end of a product's patent protection, known as the loss…
Danielle Pillsbury2024 年 10 月 21 日
Assessing Transporter-Mediated DDIs
Discover strategies for evaluating transporter-mediated drug-drug interactions (DDIs) and their impact on drug safety, efficacy,…
Danielle Pillsbury2024 年 10 月 21 日
On-ramps to popPK: Building Better Models with GUI, Code, or Both
A critical component of popPK studies is popPK modeling, where mathematical models are developed to…
Danielle Pillsbury2024 年 10 月 18 日
Why You Need an Integrated Development Plan
For a small biotech company developing its first drug asset, the path is fraught with…
Danielle Pillsbury2024 年 10 月 17 日
Certara Appoints John Reynders as New Independent Board Member
RADNOR, PA., 2024 年 10 月 16 日 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed…
Danielle Pillsbury2024 年 10 月 16 日
